Oct 23, 2024 7:30am EDT Virax Biolabs Announces Distribution Agreement with Europa Biosite to Commercialize ImmuneSelect in the United Kingdom and Ireland
Sep 16, 2024 8:30am EDT Virax Biolabs Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits with Cosmos Health Inc.
Sep 09, 2024 8:00am EDT Virax Biolabs Presents at H.C. Wainwright's 26th Annual Global Investment Conference
Aug 28, 2024 7:30am EDT Virax Biolabs Announces Distribution Agreement to Commercialize Mpox (formerly Monkeypox) Virus RT-PCR Detection Kits in Europe and the Middle East
Aug 23, 2024 4:09pm EDT Virax Biolabs Group Limited Announces Closing of $5 Million Registered Direct Offering of Ordinary Shares
Aug 21, 2024 9:30pm EDT Virax Biolabs Group Limited Announces $5 Million Registered Direct Offering of Ordinary Shares
Apr 25, 2024 8:00am EDT Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024
Mar 15, 2024 4:30pm EDT Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency
